The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Barbara Seliger

Institute of Medical Immunology

Martin-Luther University Halle-Wittenberg

Halle

Germany

[email]@*.uni-halle.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute of Medical Immunology, Martin-Luther University Halle-Wittenberg, Halle, Germany. 2010 - 2011
  • Martin-Luther-University Halle-Wittenberg, Institute of Medical Immunology, 06112 Halle (Saale), Germany. 2005 - 2011
  • Johannes Gutenberg University Mainz, 3rd Department of Internal Medicine, Mainz, Germany. 2005

References

  1. Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. Seliger, B., Dressler, S.P., Massa, C., Recktenwald, C.V., Altenberend, F., Bukur, J., Marincola, F.M., Wang, E., Stevanovic, S., Lichtenfels, R. Proteomics (2011) [Pubmed]
  2. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma? Seliger, B., Jasinski, S., Dressler, S.P., Marincola, F.M., Recktenwald, C.V., Wang, E., Lichtenfels, R. J. Proteome Res. (2011) [Pubmed]
  3. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Seliger, B., Stoehr, R., Handke, D., Mueller, A., Ferrone, S., Wullich, B., Tannapfel, A., Hofstaedter, F., Hartmann, A. Cancer Immunol. Immunother. (2010) [Pubmed]
  4. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors. Seliger, B., Massa, C., Rini, B., Ko, J., Finke, J. Trends. Mol. Med (2010) [Pubmed]
  5. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma. Seliger, B., Handke, D., Schabel, E., Bukur, J., Lichtenfels, R., Dammann, R. J. Transl. Med (2009) [Pubmed]
  6. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Seliger, B., Dressler, S.P., Wang, E., Kellner, R., Recktenwald, C.V., Lottspeich, F., Marincola, F.M., Baumgärtner, M., Atkins, D., Lichtenfels, R. Proteomics (2009) [Pubmed]
  7. Different regulation of MHC class I antigen processing components in human tumors. Seliger, B. J. Immunotoxicol (2008) [Pubmed]
  8. The complex role of B7 molecules in tumor immunology. Seliger, B., Marincola, F.M., Ferrone, S., Abken, H. Trends. Mol. Med (2008) [Pubmed]
  9. Molecular mechanisms of MHC class I abnormalities and APM components in human tumors. Seliger, B. Cancer Immunol. Immunother. (2008) [Pubmed]
  10. Structure, expression and function of HLA-G in renal cell carcinoma. Seliger, B., Schlaf, G. Semin. Cancer Biol. (2007) [Pubmed]
  11. Candidate biomarkers in renal cell carcinoma. Seliger, B., Dressler, S.P., Lichtenfels, R., Kellner, R. Proteomics (2007) [Pubmed]
  12. Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Seliger, B., Fedorushchenko, A., Brenner, W., Ackermann, A., Atkins, D., Hanash, S., Lichtenfels, R. Clin. Cancer Res. (2007) [Pubmed]
  13. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Seliger, B., Ritz, U., Ferrone, S. Int. J. Cancer (2006) [Pubmed]
  14. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. Seliger, B., Lichtenfels, R., Atkins, D., Bukur, J., Halder, T., Kersten, M., Harder, A., Ackermann, A., Malenica, B., Brenner, W., Zobawa, M., Lottspeich, F. Proteomics (2005) [Pubmed]
  15. Strategies of tumor immune evasion. Seliger, B. BioDrugs (2005) [Pubmed]
 
WikiGenes - Universities